Search Results - Gabbay, Felicity J

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD

    Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD by Monk, Phillip D, Brookes, Jody L, Tear, Victoria J, Batten, Toby N, Newall, Clare, Mankowski, Marcin, Crooks, Michael G, Singh, Dave, Chaudhuri, Rekha, Leaker, Brian, Lunn, Kerry, Reynolds, Sophie, Dudley, Sarah, Gabbay, Felicity J, Holgate, Stephen T, Djukanovic, Ratko, Wilkinson, Thomas Ma

    Published in Respiratory research
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Evolution of the Development of Core Competencies in Pharmaceutical Medicine and Their Potential Use in Education and Training

    Evolution of the Development of Core Competencies in Pharmaceutical Medicine and Their Potential Use in Education and Training by Stonier, Peter D, Silva, Honorio, Boyd, Alan, Criscuolo, Domenico, Gabbay, Felicity J, Imamura, Kyoko, Kesselring, Gustavo, Kerpel-Fronius, Sandor, Klech, Heinrich, Klingmann, Ingrid

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study

    Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study by Monk, Phillip D, Brookes, Jody L, Tear, Victoria J, Batten, Toby N, Mankowski, Marcin, Adzic-Vukicevic, Tatjana, Crooks, Michael G, Dosanjh, Davinder P S, Kraft, Monica, Brightling, Christopher E, Gabbay, Felicity J, Holgate, Stephen T, Djukanovic, Ratko, Wilkinson, Tom M A

    Published in ERJ open research
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

    Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial by Monk, Phillip D, Marsden, Richard J, Tear, Victoria J, Brookes, Jody, Batten, Toby N, Mankowski, Marcin, Gabbay, Felicity J, Davies, Donna E, Holgate, Stephen T, Ling-Pei, Ho, Clark, Tristan, Djukanovic, Ratko, Tom M A Wilkinson on behalf of the Inhaled Interferon Beta COVID-19 Study Group

    Request full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Nebulised interferon beta-1a (SNG001) in hospitalised COVID-19: SPRINTER Phase III Study

    Nebulised interferon beta-1a (SNG001) in hospitalised COVID-19: SPRINTER Phase III Study by Monk, Phillip D, Brookes, Jody L, Tear, Victoria J, Batten, Toby N, Mankowski, Marcin, Adzic-Vukicevic, Tatjana, Crooks, Michael G, Dosanjh, Davinder PS, Kraft, Monica, Brightling, Christopher E, Gabbay, Felicity J, Holgate, Stephen T, Djukanovic, Ratko, Wilkinson, Tom MA

    Published in ERJ open research
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    375. The Effect of Inhaled Interferon Beta-1a (SNG001) Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in Chronic Obstructive Pulmonary Disease (COPD) Patients With Respiratory Virus Infections

    375. The Effect of Inhaled Interferon Beta-1a (SNG001) Treatment Compared to Placebo on Lung Antiviral Biomarkers and Viral Clearance in Chronic Obstructive Pulmonary Disease (COPD... by Monk, Phillip D, Brookes, Jody L, Tear, Victoria J, Batten, Toby, Newall, Clare, Mankowski, Marcin, Crooks, Michael G, Singh, Dave, Chaudhuri, Rekha, Lunn, Kerry, Reynolds, Sophie, Dudley, Sarah, Gabbay, Felicity, Holgate, Stephen T, Djukanovic, Ratko, Wilkinson, Tom

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: